Dr. Prakash Kaur, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 311 7th Street, New Kensington, PA 15068 Phone: 724-335-1200 Fax: 724-335-0113 |
News Archive
QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).
The latest results from a 25-year study of diet and aging in monkeys shows a significant reduction in mortality and in age-associated diseases among those with calorie-restricted diets.
A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.
Research is an important component of academic medicine, but many family medicine departments have struggled with barriers ranging from departmental culture to the lack of resources needed to advance the field.
› Verified 7 days ago